default author photo

Daolin Tang

University of Texas at Dallas - Southwestern Medical Center

2601 North Floyd Road

Richardson, TX 75083

United States

SCHOLARLY PAPERS

2

DOWNLOADS

93

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Bilirubin Restrains the Anticancer Effects of Vemurafenib on BRAF-Mutant Melanoma Cells via ERK-MNK1 Signaling

Number of pages: 27 Posted: 07 Apr 2021
Xiaoyu Zhong, Yufan Tan, Xizhi Wen, Leyi Yao, Zhenlong Shao, Wenshuang Sun, Jiawen Wu, Guanmei Wen, Daolin Tang, Xiaoshi Zhang, Yuning Liao and Jinbao Liu
Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Biotherapy Center, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, University of Texas at Dallas - Southwestern Medical Center, Sun Yat-Sen University (SYSU) - State Key Laboratory of Oncology in South China, Biotherapy Center, Guangzhou Medical University - Affiliated Cancer Hospital & Institute and Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation
Downloads 51 (1,052,702)

Abstract:

Loading...

bilirubin, vemurafenib, ERK, MNK1, BRAF-mutant melanoma

2.

Parkin Facilitates Proteasome Inhibitor-Induced Apoptosis via Suppression of NF-κB Activity in Hepatocellular Carcinoma

Number of pages: 37 Posted: 27 May 2019
Xiaolan Zhang, Chun Lin, Junwei Song, Han Chen, Xuhong Chen, Liangliang Ren, Zhongqiu Zhou, Jinyuan Pan, Zhenjun Yang, Wenhao Bao, Xueping Ke, Jianan Yang, Yingying Liang, Hongbiao Huang, Daolin Tang, Lili Jiang and Jinbao Liu
Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Shenzhen University - Health Sciences Center, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Sun Yat-sen University (SYSU) - Department of Biochemistry, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Third Affiliated Hospital, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, Guangzhou Medical University - Affiliated Cancer Hospital & Institute, University of Texas at Dallas - Southwestern Medical Center, Guangzhou Medical University - Affiliated Cancer Hospital & Institute and Guangzhou Medical University - Key Laboratory of Protein Modification and Degradation
Downloads 42 (1,170,409)

Abstract:

Loading...

Proteasome inhibitors; Parkin; NF-κB; HCC; apoptosis